3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colonic Neoplasms
3
Breast Neoplasms
3
Motor Activity
2
Leiomyoma
2
Warts
1
Stomach Neoplasms
1
Psychological Well-Being
1
Psoriasis
1
Prostatic Neoplasms
1
Osteoporosis
1
Osteoarthritis
1
Obesity
1
Nasopharyngeal Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Helicobacter Infections
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Chemotherapy-Related Cognitive Impairment
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
pembrolizumab
44
Gemcitabine
23
enfortumab vedotin
21
Nivolumab
20
Cisplatin
17
avelumab
16
Magnetic Resonance Spectroscopy
15
Carboplatin
14
atezolizumab
13
Specimen Handling
12
Docetaxel
11
sacituzumab govitecan
9
Paclitaxel
8
Ipilimumab
8
durvalumab
6
Mitomycin
5
Fluorodeoxyglucose F18
5
cabozantinib
4
Taxes
4
toripalimab
3
pemigatinib
3
erdafitinib
3
X-Rays
3
Radiosurgery
3
Platinum
3
Pemetrexed
3
Immunoglobulin G
3
CTLA-4 Antigen
3
Biopsy
3
ALT-803
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Vitamin D
×
1 year
×
Clear all
No trials found.